Dishman Carbogen Amcis Ltd.

DCAL

Market Cap
₹3,438 Cr.
P/E
0.00

Dishman Carbogen Amcis Ltd.

Quick View
  • 1d
  • 1m
  • 6m
  • YTD
  • 1y
  • 3y
  • 5y
  • 10y
  • max
locked

Company Timeline

Company Timeline

Subscribe now for more updates
Forensics
Other Income
Other Income is not affecting ratios of the company
Depreciation Effect
Company is depreciating a lower percentage of assets. This is contributing to an increase in Net Profit
Pledge
Promoters have not pledged a significant portion of their holding
Revenue Recognition
Company is converting accounting profit to cash
Capex vs ROCE
ROCE of the company has increased over the last three years
Contingent Liabilities
Company does not have significant contingent liabilities
Retail Holding
Retail has been selling the stock which is usually a good time to buy
Share price
Share price has decreased over last 10 years more due to earnings
ROE
Asset Turnover is responsible for ROE increase over last 10 years
Working Capital
Company has significant working capital which is dragging its ROCE and ROE
Debt
Company might have issues servicing its debt
Promoter Holding
Promoter has not sold any shares in the last 90 days
Current vs Historic Valuation
Company is trading at a premium to 3 year historic valuations
ROE
Latest
-0.51%
3yr Average
-1.03%
5yr Average
0.72%
Net Profit Margin
Latest
-1.24%
3yr Average
-3.01%
5yr Average
1.79%
ROCE
Latest
1.04%
3yr Average
0.68%
5yr Average
2.38%
Debt to Equity
Latest
0.31
3yr Average
0.26
5yr Average
0.23
Revenue mix

Product Wise Break-Up

locked
Source
|
Latest
|
locked
Historic

Segment Break-Up -Marketable Molecules

locked
Source
|
Latest
|
locked
Historic

Location Wise Break-Up -Contract Research & Contract Manufacturing (CRAMS)

locked
Source
|
Latest
|
locked
Historic

Location Wise Break-Up

locked
Source
|
Latest
|
locked
Historic

Therapeutic Area Break-Up

locked
Source
|
Latest
|
locked
Historic

Operating Profit Break-Up

locked
Source
|
Latest
|
locked
Historic
Show more
Operational Metrics

    locked
    Select a Metric
    • US DMF Filings (.)
    • Total reactor capacity (kL)
      Source
    • R&D as a % of Total Sales (%)
      Source
    Peer Comparison
    Company Filing
    Show Previous Years
    Discussions & Analysis
    Dishman Carbogen Amcis Ltd.
    View the discussion on ValuePickr
    Pharmaceutical Sector
    How The Pharma Industry Works - PPFAS
    Phama Industry - Terminologies and Value Chain - Alpha Invesco
    Deep Dive into Pharma Sector - Omkara Capital
    Pharma Compliance In-Depth - Amit Rajan
    Nutraceuticals - The Next Gem of Healthcare Sector - Shuchi Nahar
    Nutraceuticals- Industry Overview - Value Educator
    Generic Opportunity for Indian Pharma Companies - Anish Moonka
    timeline